✦ LIBER ✦

Disease-modifying drugs in multiple sclerosis: a review of expenditure in Ireland

✍ Scribed by B. Bailey

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease-modifying drugs for multiple scl

✍ Lu, E.; Wang, B. W.; Guimond, C.; Synnes, A.; Sadovnick, D.; Tremlett, H. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 252 KB

Postmarketing evidence of disease-modify

✍ Maria Trojano; Damiano Paolicelli; Aurora Fuiani; Fabio Pellegrini; Pietro Iaffa 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 33 KB

Long-term experience with current diseas

✍ Corey C. Ford 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 321 KB

Patient Preferences in the Choice of Dis

✍ Bergmann, A.; Lang, M.; Bischoff, C.; Schicklmaier, P.; Schiffhorst, G.; Nolting 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PND45 USE OF DISEASE-MODIFYING DRUGS IN

✍ K Noyes; A Bajorska; S Schwid; R Holloway; A Dick 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PND21 FIRST USE OF DISEASE-MODIFYING DRU

✍ DM Meletiche; C Kozma; M Dickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB